Global Pharmaceuticals & Biotech Most Popular Stocks

Cipla

Market Cap: ₹1.2t

Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.

CSPC Pharmaceutical Group

Market Cap: HK$106.3b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

Torrent Pharmaceuticals

Market Cap: ₹1.2t

Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

ICON

Market Cap: US$13.0b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Eurofins Scientific

Market Cap: €10.8b

Provides various analytical testing and laboratory services worldwide.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.5b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

WuXi XDC Cayman

Market Cap: HK$94.2b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

Dr. Reddy's Laboratories

Market Cap: ₹1.1t

Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.

Ascendis Pharma

Market Cap: US$11.7b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Mankind Pharma

Market Cap: ₹1.0t

Develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally.

Zydus Lifesciences

Market Cap: ₹1.0t

Engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally.

Viatris

Market Cap: US$11.3b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Shanghai Fosun Pharmaceutical (Group)

Market Cap: CN¥76.5b

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Ipsen

Market Cap: €9.2b

Operates as a biopharmaceutical company worldwide.

Orion Oyj

Market Cap: €9.1b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Exelixis

Market Cap: US$10.5b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

BioMarin Pharmaceutical

Market Cap: US$10.3b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Ionis Pharmaceuticals

Market Cap: US$10.2b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Exact Sciences

Market Cap: US$10.2b

Provides cancer screening and diagnostic test products in the United States and internationally.

Swedish Orphan Biovitrum

Market Cap: SEK 96.2b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Lupin

Market Cap: ₹896.2b

Operates as a pharmaceutical company in India, the United States, and internationally.

Moderna

Market Cap: US$10.1b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Roivant Sciences

Market Cap: US$10.0b

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.

Beijing Wantai Biological Pharmacy Enterprise

Market Cap: CN¥70.8b

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

CSPC Innovation Pharmaceutical

Market Cap: CN¥70.7b

Engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally.

Revvity

Market Cap: US$9.8b

Provides health sciences solutions, technologies, and services.

Qiagen

Market Cap: US$9.8b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Eisai

Market Cap: JP¥1.5t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.

Shenzhen Salubris Pharmaceuticals

Market Cap: CN¥69.5b

Shenzhen Salubris Pharmaceuticals Co., Ltd.

BridgeBio Pharma

Market Cap: US$9.7b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Caliway Biopharmaceuticals

Market Cap: NT$291.6b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

Madrigal Pharmaceuticals

Market Cap: US$9.5b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

3SBio

Market Cap: HK$73.5b

An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.

Elanco Animal Health

Market Cap: US$9.3b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Verona Pharma

Market Cap: US$9.2b

A biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.

Halozyme Therapeutics

Market Cap: US$8.8b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.